Prevention and treatment of gastrointestinal mucosal injury with cytoprotective agents.
Tarnawski
A
A
D000535:Aluminum / Q000627:therapeutic use; D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use; D005753:Gastric Mucosa / Q000187:drug effects*; D005767:Gastrointestinal Diseases / Q000188:drug therapy* / Q000517:prevention & control; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D009942:Organometallic Compounds; D011453:Prostaglandins / Q000627:therapeutic use*; D012377:Rodentia; D013392:Sucralfate
D001095:Arachidonic Acids; D006635:Histamine H2 Antagonists; D009942:Organometallic Compounds; D011453:Prostaglandins; D016718:Arachidonic Acid; D013392:Sucralfate; D000535:Aluminum; C002791:bismuth tripotassium dicitrate; D001729:Bismuth